Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Shadforth

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|December 22, 2004
The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactionsA J Kinder, A B Hassell, J Brand, et al.
British Journal of Rheumatology|December 1, 1991
Should disease-modifying agents be used in mild rheumatoid arthritis?M J Davis, P T Dawes, P D Fowler, et al.
Clinical and Experimental Rheumatology|May 1, 1991
Raised epidermal phospholipase A2 activity in rheumatoid arthritisH G Taylor, P T Dawes, A Ilchyshyn, et al.
Annals of the Rheumatic Diseases|November 1, 1986
Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapyP T Dawes, P D Fowler, R Jackson, et al.
The Journal of Rheumatology|October 1, 1983
Acetylator phenotype and the effect of dapsone in rheumatoid arthritisP R Crook, C Hortas, E J Roberts, et al.
Scandinavian Journal of Rheumatology|January 1, 1991
The association and predictive value of the complex immunoglobulin A-alpha 1-antitrypsin in the development of erosions in early rheumatoid arthritisM J Davis, P T Dawes, P D Fowler, et al.
British Journal of Rheumatology|April 1, 1990
Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritisM J Davis, P T Dawes, P D Fowler, et al.
Annals of the Rheumatic Diseases|September 14, 2004
A comparison of four shoulder-specific questionnaires in primary careA Paul, M Lewis, M F Shadforth, et al.
British Journal of Rheumatology|April 1, 1997
Management of oral complications of disease-modifying drugs in rheumatoid arthritisE H Carpenter, M J Plant, A B Hassell, et al.
The Quarterly Journal of Medicine|September 1, 1993
The relationship between serial measures of disease activity and outcome in rheumatoid arthritisA B Hassell, M J Davis, P D Fowler, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|December 22, 2004
The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactionsA J Kinder, A B Hassell, J Brand, et al.
British Journal of Rheumatology|December 1, 1991
Should disease-modifying agents be used in mild rheumatoid arthritis?M J Davis, P T Dawes, P D Fowler, et al.
Clinical and Experimental Rheumatology|May 1, 1991
Raised epidermal phospholipase A2 activity in rheumatoid arthritisH G Taylor, P T Dawes, A Ilchyshyn, et al.
Annals of the Rheumatic Diseases|November 1, 1986
Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapyP T Dawes, P D Fowler, R Jackson, et al.
The Journal of Rheumatology|October 1, 1983
Acetylator phenotype and the effect of dapsone in rheumatoid arthritisP R Crook, C Hortas, E J Roberts, et al.
Scandinavian Journal of Rheumatology|January 1, 1991
The association and predictive value of the complex immunoglobulin A-alpha 1-antitrypsin in the development of erosions in early rheumatoid arthritisM J Davis, P T Dawes, P D Fowler, et al.
British Journal of Rheumatology|April 1, 1990
Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritisM J Davis, P T Dawes, P D Fowler, et al.
Annals of the Rheumatic Diseases|September 14, 2004
A comparison of four shoulder-specific questionnaires in primary careA Paul, M Lewis, M F Shadforth, et al.
British Journal of Rheumatology|April 1, 1997
Management of oral complications of disease-modifying drugs in rheumatoid arthritisE H Carpenter, M J Plant, A B Hassell, et al.
The Quarterly Journal of Medicine|September 1, 1993
The relationship between serial measures of disease activity and outcome in rheumatoid arthritisA B Hassell, M J Davis, P D Fowler, et al.
Pageof 4